Join the Oncology Voice Network. Join for Free
All About Thought Leader Liaison
Thought Leader Engagement Pharma Industry Key Opinion Leaders Strategic Relationships Healthcare Professionals

All About Thought Leader Liaison


Share This Article


Summary

This weeks guest is Jim Hahn, Senior Business Director, Thought Leader Engagement at EMD Serono who discusses the role of the Thought Leader Liaison and how it fits into the pharma world.

Key Points

  • Thought leader liaisons (TLLs) focus on building deep, strategic relationships with key opinion leaders (KOLs) to align commercial objectives with the needs of healthcare providers.
  • TLLs typically come from successful sales backgrounds and do not require advanced scientific degrees, but must have strong interpersonal skills and a thorough understanding of their therapeutic area.
  • Effective communication between TLLs, MSLs, and sales reps is crucial to ensure seamless interactions with healthcare professionals and to avoid conflicts over access and time.

This weeks guest is Jim Hahn, Senior Business Director, Thought Leader Engagement at EMD Serono who discusses the role of the Thought Leader Liaison and how it fits into the pharma world.

Click for Source
Thought Leader Engagement, Pharma Industry, Key Opinion Leaders, Strategic Relationships, Healthcare Professionals

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Podcast
How Should Medical Affairs Engage on Social Media
Partner Avatar MSL Talk: Tom Caravela

How Should Medical Affairs Engage on Social Media

Press Release
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
OVN Avatar OVN Staff

Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Explore OVN